A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells use to evade treatment, while also activating the immune system to attack — with 15 patients seeing their tumours completely disappear in the trial.

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

A promising triple-action cancer jab being trialled at the Royal Marsden has shown encouraging results for some patients with head and neck cancer, with tumours disappearing…